Article Information
History
- August 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- David Prihodaa,b,
- Jad Maamaryc,
- Andrew Waightd,
- Veronica Juand,
- Laurence Fayadat-Dilmand,
- Daniel Svozila,e and
- Danny A. Bittonb,✉
- aCZ-OPENSCREEN: National Infrastructure for Chemical Biology, Department of Informatics and Chemistry, University of Chemistry and Technology, Prague, Czech Republic
- bR&D Informatics Solutions, MSD Czech Republic s.r.o., Prague, Czech Republic
- cPredictive and Clinical Immunogenicity, Merck & Co., Inc., Kenilworth, New Jersey, USA
- dDiscovery Biologics, Protein Sciences, MRL, Merck & Co., Inc., 213 E. Grand Avenue, South San Francisco, CA, USA
- eCZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Vídeňská 1083, 142 20 Prague 4, Czech Republic
- ↵✉Correspondence: danny.bitton{at}merck.com
Posted August 08, 2021.
BioPhi: A platform for antibody design, humanization and humanness evaluation based on natural antibody repertoires and deep learning
